IVA(IVA)
IVA
ANALYST COVERAGE8 analysts
BUY
▲ +190.6%upside to target
L $12.00
Med $15.00consensus
H $24.00Key MetricsTTM
Market Cap$625.78M
Revenue TTM$13.68M
Net Income TTM-$537.03M
Free Cash Flow-$194.66M
Gross Margin35.1%
Operating Margin-3037.3%
Net Margin-7899.6%
Return on Equity1870.4%
Return on Assets-141.9%
Debt / Equity-2.10
Current Ratio3.16
EPS TTM$-0.56
PRICE
Prev Close
5.21
Open
5.21
Day Range5.15 – 5.28
5.15
5.28
52W Range2.85 – 7.98
2.85
7.98
45% of range
VOLUME & SIZE
Avg Volume
332.5K
FUNDAMENTALS
P/E Ratio
-2.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
58
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 119 days
Sep 18
IVA News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Frederic Cren
Country
France
Website
Eric DuransonGeneral Counsel
Jason A. CampagnaPresident of Research & Development and Chief Medical Officer
Pamela HerbsterChief People Officer
Andrew ObenshainChief Executive Officer
Axel-Sven MalkomesChief Financial Officer
Jean VolatierExecutive VP Finance & Corporate Social Responsibility
Martine ZimmermannExecutive VP of Regulatory Affairs & Quality Assurance and Head of Regulatory Affairs
Pierre BroquaCo-Founder
Nathalie HarroyHead of Human Resources
Nazira AmraChief Commercial Strategy Officer
Pascaline ClercExecutive Vice President of External and Corporate Affairs
Susan ColesChief Legal Officer